Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study Group

DSpace Repository

Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study Group

Author: Fenner, Martin; Oing, Christoph; Dieing, Annette; Gauler, Thomas; Oechsle, Karin; Lorch, Anja; Hentrich, Marcus; Kopp, Hans-Georg; Bokemeyer, Carsten; Honecker, Friedemann
Tübinger Autor(en):
Kopp, Hans-Georg
Published in: Journal of Cancer Research and Clinical Oncology (2019), Bd. 145, H. 3, S. 717-723
Verlagsangabe: Springer
Language: English
Full text: http://dx.doi.org/10.1007/s00432-018-2752-z
ISSN: 1432-1335
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)